Infliximab anti-drug antibody (ADA) detection by homogenous mobility shift assay (HMSA): Potential clinical utility of neutralising (NADA) vs non-neutralising binding ADA (BADA)

Pathology(2022)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要